Synthesis of 4-(3'-[125I]iodoanilino)-6,7-dialkoxyquinazolines: Radiolabeled epidermal growth factor receptor tyrosine kinase inhibitors

被引：0
|
作者：
Lim, John K. [1 ,2 ]
Negash, Kitaw [1 ,3 ]
Hanrahan, Stephen M. [1 ]
Vanbrocklin, Henry F. [1 ]
机构：
[1] Lawrence Berkeley National Laboratory, University of California, MS 55-121, 1 Cyclotron Rd., Berkeley, CA 94720, United States
[2] Department of Radiology, University of California, San Francisco, CA 94143, United States
[3] American Cyanamide Co., Agricultural Research Division, Princeton, NJ 08543, United States
来源：
Journal of Labelled Compounds and Radiopharmaceuticals | 2000年 / 43卷 / 12期
关键词：
Amino acids - Enzyme inhibition;
D O I：
10.1002/1099-1344(20001030)43:123.0.CO;2-N
中图分类号：
学科分类号：
摘要：
The preparation of two radioiodinated analogs of the epidermal growth factor receptor tyrosine kinase (EGFrTK) inhibitor PD153035 (4-(3'-bromoanilino)-6,7-dimethoxyquinazoline) are reported herein. The two analogs, 4-(3'-[125I]iodoanilino)-6,7-dimethoxyquinazoline and 4-(3'-[125I]iodoanilino)-6,7-diethoxyquinazoline, were synthesized via iododestannylation of the corresponding 4-(3'-trimethylstannylanilino)-6,7-dialkoxyquinazolines to form the desired I-125 labeled products in good yield, high radiochemical purity (>99%) and high specific activity.
引用
收藏
页码：1183 / 1191
相关论文
共 50 条
  • [41] 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity
    Tsou, HR
    Mamuya, N
    Johnson, BD
    Reich, MF
    Gruber, BC
    Ye, F
    Nilakantan, R
    Shen, R
    Discafani, C
    DeBlanc, R
    Davis, R
    Koehn, FE
    Greenberger, LM
    Wang, YF
    Wissner, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) : 2719 - 2734
  • [42] First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review
    Sidrak, Marko Magdi Abdou
    De Feo, Maria Silvia
    Frantellizzi, Viviana
    Marongiu, Andrea
    Caponnetto, Salvatore
    Filippi, Luca
    Nuvoli, Susanna
    Spanu, Angela
    Schillaci, Orazio
    De Vincentis, Giuseppe
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (04) : 232 - 245
  • [43] Tyrosine kinase inhibitors.: 17.: Irreversible inhibitors of the epidermal growth factor receptor:: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]-pyrimidine-6-acrylamides bearing additional solubilizing functions (vol 43, pg 1380, 2000)
    Smaill, JB
    Rewcastle, GW
    Bridges, AJ
    Zhou, HR
    Showalter, HDH
    Fry, DW
    Nelson, JM
    Sherwood, V
    Elliott, WL
    Vincent, PW
    DeJohn, DE
    Loo, JA
    Greis, KD
    Chan, OH
    Reyner, EL
    Lipka, E
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (16) : 3199 - 3199
  • [44] INTERESTing Biomarker to Select IDEAL Patients for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Yes, for EGFR Mutation Analysis, Others, I PASS
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 713 - 715
  • [45] Tyrosine kinase inhibitors .11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: Synthesis, biological evaluation, and modeling of the mode of binding
    Palmer, BD
    TrumppKallmeyer, S
    Fry, DW
    Nelson, JM
    Showalter, HDH
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) : 1519 - 1529
  • [46] Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase
    Yoshimi Murozuka
    Naoko Watanabe
    Kenichi Hatanaka
    Sen-itiroh Hakomori
    Glycoconjugate Journal, 2007, 24 : 551 - 563
  • [47] Lyso-GM3, its dimer, and multimer: their synthesis, and their effect on epidermal growth factor-induced receptor tyrosine kinase
    Murozuka, Yoshimi
    Watanabe, Naoko
    Hatanaka, Kenichi
    Hakomori, Sen-itiroh
    GLYCOCONJUGATE JOURNAL, 2007, 24 (09) : 551 - 563
  • [48] SYNTHESIS OF A SERIES OF ARYL-SUBSTITUTED BENZYLIDENE NITRILES AND RELATED-COMPOUNDS AS INHIBITORS OF THE EPIDERMAL GROWTH FACTOR-RECEPTOR PROTEIN TYROSINE KINASE
    PERSONS, PE
    LY, CQ
    SPADA, AP
    LYALL, RM
    ZILBERSTEIN, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 119 - MEDI
  • [49] Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase
    Zhu, Zhen-Wei
    Shi, Lei
    Ruan, Xiao-Ming
    Yang, Ying
    Li, Huan-Qiu
    Xu, Suo-Ping
    Zhu, Hai-Liang
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2011, 26 (01) : 37 - 45
  • [50] Specificity of α-cyano-β-hydroxy-β-methyl-N-[4-(trifluoromethoxy)phenyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase
    Ghosh, S
    Zheng, YG
    Jun, X
    Mahajan, S
    Mao, C
    Sudbeck, EA
    Uckun, FM
    CLINICAL CANCER RESEARCH, 1999, 5 (12) : 4264 - 4272
12345